Antimicrobial Resistance: A Global Perspective

  • Stuart B. Levy
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 390)


Antimicrobial resistance is of concern to many of us. However, despite a call for action, we ofttimes seem to be speaking to the wind. As the problem advances, we wonder when and how medical and public health measures will deal with it. Resistance is not local or national, it is international. It is not just in one hospital or community, but in hospitals and communities worldwide. Therefore, if we are going to curtail the problem we have to approach it on a global scale.


Antibiotic Resistance Multidrug Resistance Antimicrobial Resistance Streptococcus Pneumoniae Resistant Bacterium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    S.B. Levy. Starting Life Resistance-free. New Eng J Med. 323: 335–337 (1990).PubMedCrossRefGoogle Scholar
  2. 2.
    S.B. Levy. “The Antibiotic Paradox: How Miracle Drugs are Destroying the Miracle.” Plenum Publishing Corp., New York (1992).Google Scholar
  3. 3.
    M.L. Cohen. Epidemiology of drug resistance: implications for a post antimicrobial era. Science. 257: 1050–1054 (1992).PubMedCrossRefGoogle Scholar
  4. 4.
    H.C. Neu. The crisis in antibiotic resistance. Science. 257: 1064–1072 (1992).PubMedCrossRefGoogle Scholar
  5. 5.
    S.B. Levy. Ecology of antibiotic resistance determinants. In: “Antibiotic Resistance Genes: Ecology, Transfer and Expression,” S.B. Levy and R.P. Novick, eds., Cold Spg. Harbor Press, New York pp. 17–29 (1986).Google Scholar
  6. 6.
    T. Akiba, L. Koyama, Y. Ishiki, S. Kimura, and T. Rukushima. On the mechanism of the development of multiple drug resistant clones of Shigella. Jap J Microbiol. 4: 219–227 (1960).PubMedGoogle Scholar
  7. 7.
    M.F. DeFlaun and S.B. Levy. Genes and their varied hosts. In: “Gene Transfer in the Enviroment,” S.B. Levy and R.V. Miller eds., McGraw-Hill, New York (1989) p. 1–32.Google Scholar
  8. 8.
    L.W. Riley, E. Arathoon, and V.B. Loverde. The epidemiologic patterns of drug-resistant Mycobacterium tuberculosis infection: a community-based study. Am Rev Respir Dis. 139: 1282–1285 (1989).PubMedCrossRefGoogle Scholar
  9. 9.
    R. Munoz, T.J. Coffey, M. Daniels, C.G. Dowson, G. Laible, J. Casal, R. Hakenbeck, M. Jacobs, J.M. Musser, B.G. Spratt, and A. Tomasz. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis. 164: 302–306 (1991).PubMedCrossRefGoogle Scholar
  10. 10.
    S.B. Levy, G.B. FitzGerald, and A.B. Macone. Spread of antibiotic resistance plasmids from chicken to chicken and from chicken to man. Nature. 260: 40–42 (1976).PubMedCrossRefGoogle Scholar
  11. 11.
    R. Rolland, G. Hausfater, B. Marshall, and S.B. Levy. Increased frequency of antibiotic resistant gut flora in wild baboons in contact with human refuse. Appl. Environ. Microbiol. 49: 791–794 (1985).Google Scholar
  12. 12.
    B.R. Bloom and C.J.L. Murray. Tuberculosis: commentary on a re-emergent killer. Science. 257: 1055–1063 (1992).PubMedCrossRefGoogle Scholar
  13. 13.
    K.L. Deuchars, K.L. and V. Ling. P-glycoprotein and multidrug resistance in cancer chemotherapy. Sem Oncol. 16: 156–165 (1989).Google Scholar
  14. 14.
    T. Watanabe. Infectious heredity of multiple drug resistance in bacteria. Bacteriol Rev. 27: 87–115 (1963).PubMedGoogle Scholar
  15. 15.
    J.A. Frost, G.A. Willshaw, E.A. Barclay, B. Rowe, P. Lemmens, and J. Vandepitte. Plasmid characterization of drug-resistant Shigella dysenteriae 1 from an epidemic in Central Africa. J Hyg. 94: 163–72 (1985).PubMedCrossRefGoogle Scholar
  16. 16.
    A. Fenoll, C.M. Bourgon, R. Munoz, D. Viciosi, and J. Casai. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979–1989. Rev Inf Dis. 13: 56–60 (1991).CrossRefGoogle Scholar
  17. 17.
    P.C. Applebaum. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis. 15: 77–83 (1992).CrossRefGoogle Scholar
  18. 18.
    S. Block, J. Hedrich, P. Wright et al. Drug resistant Streptococcus pneumoniae Kentucky and Tennessee, 1993. Morb Mortal Weekly Rep. 43: 23–25 (1993).Google Scholar
  19. 19.
    P. Geslin, A. Fremaux, and G. Sissia. Situation actuelle de la resistance des pneumocoques aux antibiotiques en France: bilan du Centre national de reference Lett del’Infect. 7: 477–486 (1993).Google Scholar
  20. 20.
    M.M. Sloas, F.F. Barrett, P.J. Chesney, B.K. English, B.C. Hill, F.C. Tenover, and R.J. Leggiadro. Cephalosporin treatment failure in penicillin-and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J. 11: 662–666 (1992).PubMedGoogle Scholar
  21. 21.
    W.L. Nelson, D.L. Kennedy, C.S. Lao, and J.N. Kuritsky. Outpatient systemic antiinfective use by children in the United States, 1977–1986. Pediat Infect Dis J. 7: 505–509 (1988).CrossRefGoogle Scholar
  22. 22.
    K. Machka, I. Braveny, H. Dabernat, K. Dornbusch, E. Van Dyck, F.H. Kayser, B. Van Klingeren, H. Mittermayer, E. Perea, and M. Powell. Distribution and resistance patterns of Hemophilus influenzae: a European cooperative study. Eur J Clin Microbiol Infect Dis. 7: 14–24 (1988).PubMedCrossRefGoogle Scholar
  23. 23.
    P.J. Collignon, J.M. Bell, S.J. Maclnnes, G.L. Gilbert, M. Toohey, and the Australian Group for Antimicrobial Resistance (AGAR). J Antimicrob Chemother. 30: 153–163 (1992).PubMedCrossRefGoogle Scholar
  24. 24.
    E. Obasecki-Ebor, S.M. Oyaides, and E.E. Okpere. Incidence of penicillinase producing Neiserria gonorrhoeae (PPNG) strains and susceptibility of gonococcal isolates to antibiotics in Benin City, Nigeria. Geniotourin Med 61: 367–70 (1985).Google Scholar
  25. 25.
    R.J. Gorwitz, A.K. Nakashima, and J.S. Moran. Sentinel surveillance for antimicrobial resistance in Neisseria gonorrhoeae-United States, 1988–1991. Morbid Mortal Weekly Rep. 42: 29–36 (1993).Google Scholar
  26. 26.
    World Health Organization. Current treatments in the control of sexually transmitted diseases. WHO/VDT/83; 43: 1–45 (1986).Google Scholar
  27. 27.
    F. Baquero, J. Martinez-Beltran, and E. Loga. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J Antimicrob Chemother. 28:Suppl. 0 31–38 (1991).CrossRefGoogle Scholar
  28. 28.
    J. Piper, L. Steele-Moore, B. Schneider, and W. Holloway. Serious infections caused by relatively resistant viridans streptococci. Abst 1049 1993 ICAAC meeting, New Orleans ASM (1993).Google Scholar
  29. 29.
    T.R. Frieden, T. Sterling, A. Pablos-Mendez, J.O. Kilburn, G.M. Cauthen, and S.W. Dooley. The emergence of drug-resistant tuberculosis in New York City. New Eng J Med 328: 521–526 (1993).PubMedCrossRefGoogle Scholar
  30. 30.
    S. Amidi, S. Solter, B. Rashidian, A.-R. Zokajan, and F. Razmjolan. Antibiotic use and abuse among physicians in private practice in Shiraz, Iran. Medical Care. 13: 341–345 (1975).PubMedCrossRefGoogle Scholar
  31. 31.
    A. DePaola, P.A. Flynn, R.M. McPhearson, and S.B. Levy. Phenotypic and genotypic characterization of tetracycline and oxytetracycline resistant Aeromonas from cultured channel catfish (Ictalurus punctatus) and their environments. Appl Env Microb. 54: 1861–1863 (1988).Google Scholar
  32. 32.
    S.B. Levy, S.B. Antibiotic use for growth promotion in animals: ecologic and public health consequences. J Food Protection. 50: 616–620 (1987).Google Scholar
  33. 33.
    S.B. Levy, G.B. Fitzgerald. and A.B. Macone. Changes in intestinal flora of farm personnel after introduction of tetracycline-supplemented feed on a farm. New Eng. J. Med. 295: 583–588 (1976).CrossRefGoogle Scholar
  34. 34.
    J.K. Moller, A.L. Bak, A. Stenderup, H. Zachariae, and H. Afzelius. Changing patterns of plasmid-mediated resistance during tetracycline therapy. Antimicrob Agents Chemother. 11: 388–391 (1977).PubMedCrossRefGoogle Scholar
  35. 35.
    W.E. Kloos. Effect of single antibiotic therapy on Staphylococcus community structure. APUA Newsletter. 5: 4: 1–2 (1987).Google Scholar
  36. 36.
    S.B. Levy. Antibiotic resistant bacteria in food of man and animals. In: “Antimicrobials and Agriculture,” M. Woodbine, ed., Butterworths, London (1984) pp. 525–531.Google Scholar
  37. 37.
    C.E. Phelps. Bug/Drug resistance. Medical Care. 27: 194–203 (1989).PubMedCrossRefGoogle Scholar
  38. 38.
    S.D. Holmberg, S.L. Solomon, and P.A. Blake. Health and economic impacts of antimicrobial resistance. Rev Inf Dis. 9: 1065–1078 (1987).CrossRefGoogle Scholar
  39. 39.
    M.L. Nelson, B.H. Park, J.S. Andrews, V.A. Georgian, R.C. Thomas, and S.B. Levy. Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5hydroxy-6-deoxy tetracyclines, J. Med.Chem. 36: 370–377 (1993).PubMedCrossRefGoogle Scholar
  40. 40.
    G.N. Robinson. Evolution of b-lactamase inhibitors. Rev. Infect. Dis. 13, Suppl. 9 5727–32 (1991).Google Scholar
  41. 41.
    I. Chopra. The magainins: antimicrobial peptides with potential for topical application. J. Antimicr. Chemother. 32: 351–353 (1993).CrossRefGoogle Scholar
  42. 42.
    S.B. Levy. Antibiotic availability and use: consequences to man and his environment. J. Clinical Epidemiology. 44:S11: 83S - 87S (1991).Google Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • Stuart B. Levy
    • 1
  1. 1.Center For Adaptation Genetics and Drug ResistanceTufts University School of MedicineBostonUSA

Personalised recommendations